Exploring Vasopressors in Clinical Care

This chapter discusses the key vasopressors, primarily epinephrine and norepinephrine, emphasizing their pharmacological differences and implications in treating conditions like septic shock. It highlights the declining use of dopamine due to associated risks, reviews efficacy and safety in post-cardiac arrest shock management, and underscores the importance of maintaining hemodynamic goals. The chapter also reflects on the presenters' backgrounds and encourages further engagement through their social media platforms.